Accumulating evidence from cancer genomics has revealed that EGFR is recurrently mutated in multiple cancer types, including lung cancer, glioblastoma, head and neck squamous cell carcinoma [8, 9]. This evidence concerns the gene EGFR and lung carcinoma.